药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Dolasetron
Aripiprazole lauroxil
The metabolism of Aripiprazole lauroxil can be increased when combined with Nifedipine.
Dolasetron
Aripiprazole
The metabolism of Aripiprazole can be increased when combined with Nifedipine.
Dolasetron
Ruxolitinib
Ruxolitinib may increase the bradycardic activities of Nifedipine.
Dolasetron
Ivabradine
Nifedipine may increase the bradycardic activities of Ivabradine.
Dolasetron
Ceritinib
Nifedipine may increase the bradycardic activities of Ceritinib.
Dolasetron
Belantamab mafodotin
Nifedipine may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level.
Dolasetron
Pralsetinib
Pralsetinib may decrease the excretion rate of Nifedipine which could result in a higher serum level.
Dolasetron
Sulfinpyrazone
Nifedipine may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level.
Dolasetron
Valinomycin
Valinomycin may decrease the excretion rate of Nifedipine which could result in a higher serum level.
Dolasetron
Letermovir
Letermovir may decrease the excretion rate of Nifedipine which could result in a higher serum level.
Dolasetron
Lenvatinib
Lenvatinib may decrease the excretion rate of Nifedipine which could result in a higher serum level.
Dolasetron
Simeprevir
Simeprevir may decrease the excretion rate of Nifedipine which could result in a higher serum level.
Dolasetron
Cholic Acid
Cholic Acid may decrease the excretion rate of Nifedipine which could result in a higher serum level.
Dolasetron
Ursodeoxycholic acid
Ursodeoxycholic acid may decrease the excretion rate of Nifedipine which could result in a higher serum level.
Dolasetron
Levodopa
The risk or severity of hypotension and orthostatic hypotension can be increased when Nifedipine is combined with Levodopa.
Hexachlorophene
Satralizumab
The serum concentration of Chlorpheniramine can be decreased when it is combined with Satralizumab.
Hexachlorophene
Oliceridine
The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Chlorpheniramine is combined with Oliceridine.
Hexachlorophene
Abametapir
The serum concentration of Chlorpheniramine can be increased when it is combined with Abametapir.
Hexachlorophene
Remimazolam
The risk or severity of sedation can be increased when Chlorpheniramine is combined with Remimazolam.
Hexachlorophene
Tucatinib
The metabolism of Tucatinib can be decreased when combined with Chlorpheniramine.